[Skip to Navigation]
Comment & Response
October 27, 2021

Biomarkers for Myocardial Infarction Type Discrimination—The Key Might Be in the Time Course of the Disease—Reply

Author Affiliations
  • 1Cardiovascular Research Institute Basel (CRIB), Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland
  • 2Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada
JAMA Cardiol. 2022;7(1):113-114. doi:10.1001/jamacardio.2021.4395

In Reply We thank Hayek and colleagues for their interest in our work on cardiovascular biomarkers in the early discrimination of type 2 myocardial infarction (T2MI) from type 1 MI (T1MI).1 We fully agree that patients with T1MI may present earlier than patients with T2MI, resulting in different stages of disease biology during the serial blood sampling in the emergency department (ED).

Add or change institution